GlassScriptPhysician profile
Christopher L Bell
NPI 1407818479
$52,558.90
in general payments reported to CMS, 2019-2025
50 companies · $18K in 2025
The $18K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,754 · 2020: $6,071 · 2021: $2,502 · 2022: $367 · 2023: $9,934 · 2024: $12K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Education: $10K · Food and Beverage: $6,101 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Travel and Lodging: $1,513 · Long Term Medical Supply Or Device Loan: $491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,760.00 |
| Education | $10,000.00 |
| Food and Beverage | $6,100.71 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Travel and Lodging | $1,513.28 |
| Long Term Medical Supply Or Device Loan | $490.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Enterra Medical, INC. | $21,770.38 | 2023-2025 | |
| Intuitive Surgical, INC. | $20,351.24 | 2019-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $3,008.32 | 2019-2023 | |
| Davol INC. | $1,253.06 | 2019-2025 | Phasix Mesh, Arista Ah Flexitip |
| Stryker Corporation | $857.47 | 2021 | |
| Medtronic, INC. | $797.01 | 2021-2025 | Signia, Ligasure, Dextile |
| Integra Lifesciences Corporation | $586.92 | 2020-2024 | Acell |
| Ethicon US, LLC | $520.96 | 2019-2025 | Linx Reflux Management System, Echelon Flex, Stratafix |
| Dilon Technologies, INC. | $438.77 | 2024-2025 | Hemoblast Bellows |
| Allergan, INC. | $265.17 | 2019-2022 | |
| Tela Bio, INC. | $262.60 | 2019-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Kerecis Limited | $261.58 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Takeda Pharmaceuticals U.S.A., INC. | $219.82 | 2020-2025 | Gattex, Eohilia |
| Biom'Up France Sas | $197.54 | 2020-2021 | |
| Novo Nordisk INC | $168.74 | 2019-2025 | Wegovy |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.